Market Place
Sourcing Support
MSN Lab`s Generics Perampanel Receives Tentative Approval in US
16 Dec 2024 //
FDA
Teva Pharms`s Generic Perampanel Receives Tentative Approval in US
04 Jun 2024 //
FDA
Eisai`s antiepileptic drug Fycompa injection formulation launches in Japan
18 Apr 2024 //
BIOSPECTRUM ASIA
Ligand Partner Eisai Receives Approval for Injection Formulation of Fycompa
22 Feb 2024 //
BUSINESSWIRE
Catalyst Announces Multiple Abstracts on FYCOMPA from Eisai to be Presented
14 Aug 2023 //
GLOBENEWSWIRE
Akums gets DCGI approval for Perampanel Oral Suspension
27 Jun 2023 //
EXPRESS PHARMA
Catalyst Announces Third-Party Abstracts on FYCOMPA® (Perampanel)
20 Apr 2023 //
GLOBENEWSWIRE
FDA Confirms Paragraph IV Patent Litigation for Perampanel Oral Suspension
13 Feb 2023 //
FDA
Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa
20 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa
20 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA
19 Dec 2022 //
GLOBENEWSWIRE
Teva Pharma Generic Perampanel Receives Tentative Approval in US
01 Jul 2022 //
FDA
Teva Pharmaceuticals USA`s Generic Perampanel Receives Approval in the U.S.
01 Apr 2022 //
FDA
Eisai Presents Its Largest Real-World Study Of FYCOMPA Across Patient Types
07 Dec 2021 //
PRNEWSWIRE
Eisai To Present New Data Evaluating FYCOMPA at AES 2021
01 Dec 2021 //
PRNEWSWIRE
Teva Pharms Usa Inc`s Generic Perampanel Receives Approval In US
26 Jun 2021 //
FDA
Accord Hlthcare`s Generic Perampanel Receives Approval In US
26 Jun 2021 //
FDA
Taro Pharm`s Generic Perampanel Receives Approval In US
17 Jun 2021 //
FDA
Accord Hlthcare`s Generic Perampanel Receives Approval In US
14 Jun 2021 //
FDA
Teva Pharms Usa`s Generic Perampanel Receives Approval In US
14 Jun 2021 //
FDA
European Commission Approves Anti-Epileptic Fycompa as Adjunct for Children
12 Nov 2020 //
FDANEWS
Eisai gets positive opinion from EMA`s CHMP on use of Fycompa
24 Sep 2020 //
PHARMABIZ
Eisai receives EMA`s CHMP approval for Fycompa for pediatric use
22 Sep 2020 //
BIOSPECTRUMASIA
Eisai introduces new fine granule formulation of antiepileptic drug Fycompa
06 Jul 2020 //
PHARMABIZ
Approval Of Antiplileptic Drug FYCOMPA® In Japan
23 Jan 2020 //
PRESS RELEASE
Eisai launches antiepileptic drug in China
09 Jan 2020 //
BIOSPECTRUM ASIA
Eisai to Present Convulsive Seizure Freedom Data Evaluating FYCOMPA®
25 Nov 2019 //
PR NEWSWIRE
China approves Eisai`s Fycompa for partial onset epileptic seizures
16 Oct 2019 //
PHARMAFILE
Epilepsy Patients Treated With Adjunctive FYCOMPA® (perampanel) CIII
09 May 2019 //
PR NEWSWIRE
Doctors are watching, FDA promo police`s latest rebuke shows
29 Oct 2018 //
FIERCE PHARMA
Eisai and Oklahoma Health Care Authority Enter Value-Based Agreement for FYCOMPA
26 Oct 2018 //
PR NEWSWIRE
Eisai Receives FDA Priority Review Designation for FYCOMPA® CIII Pediatric indic
30 May 2018 //
PR NEWSWIRE
Eisai seeks US FDA approval for Fycompa to treat pediatric patients
02 Apr 2018 //
PHARMABIZ
Eisai Submits sNDA to FDA for FYCOMPA® (perampanel) Pediatric Indications
29 Mar 2018 //
PR NEWSWIRE
Eisai introduces first-in-Class Epilepsy Treatment Fycompa (Perampanel) in India
23 Aug 2017 //
BIOSPECTRUM
FDA Approves Eisai`s FYCOMPA® (perampanel) for Use as Monotherapy
26 Jul 2017 //
PR NEWSWIRE
Japanese Companies Make Cautious Return to Indian Pharma Market
04 Jan 2017 //
ECONOMIC TIMES
Pharma already balks at Germany`s tough pricing regime
14 Nov 2016 //
FIERCE PHARMA
Eisai Announces Initiation of Two Phase 3 Clinical Trials with FYCOMPA®
28 Oct 2016 //
PR NEWS WIRE
Eisai Submits Application to FDA for Use of its Antiepileptic Drug FYCOMPA
27 Sep 2016 //
PR NEWSWIRE
FYCOMPA® (perampanel) Oral Suspension Now Available as an Option
15 Jun 2016 //
PR NEWSWIRE
EISAI`s Fycompa (Perampanel) approved in US for Epilepsy
29 Apr 2016 //
FDA
Presentation pooled phase III at AES on the use of Fycompa®
09 Dec 2015 //
PR NEWS WIRE
Presented new data, the use of Zebinix to treat partial onset seizure at AES
09 Dec 2015 //
PR NEWS WIRE
PhIII pooled data presented at the 2015 Congress of the AES on Fycompa
07 Dec 2015 //
PR NEWS WIRE
Zebinix® (eslicarbazepine acetate) in the treatment of partial seizures
07 Dec 2015 //
PR NEWS WIRE
Struggling Eisai looks for help in China with new generics deal
04 Dec 2015 //
FIERCE PHARMA
Eisai Present Data on Perampanel and First and Largest US Study on Epilepsy
02 Dec 2015 //
PR NEWS WIRE
Eisai Announces Change of access to Fycompa® (perampanel) in Germany
05 Nov 2015 //
PR NEWSWIRE
Phase III data back efficacy of Fycompa in epilepsy
09 Sep 2015 //
PHARMATIMES
Eisai`s Fycompa debuts in UK for serious epileptic seizures
07 Jul 2015 //
PHARMA TIMES
Eisai predicts long-awaited operating profit rise for fiscal 2015
15 May 2015 //
FIERCE PHARMA
UPDATED: Eisai to Shed 200-plus Jobs as it Pares Down U.S. Workforce
10 Apr 2015 //
FIERCE PHARMA
CSA Legislation Reintroduced to Speed Up DEA
29 Jan 2015 //
FDA LAW BLOG
